Who owns ETF AMPLIFY TR TREATMENTS TESTING & ADVANCEMEN?
- CUSIP Number: 032108581
Tip: Access positions for across all investors
Analyze quarterly positions in Etf Amplify Tr Treatments Testing & Advancemen with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Etf Amplify Tr Treatments Testing & Advancemen stock
Who bought or sold ETF AMPLIFY TR TREATMENTS TESTING & ADVANCEMEN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 41k | $761k | 100% | Mar 2024 |
|
| Citadel Advisors | 16k | $298k | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 1.5k | $27k | 100% | Mar 2024 |
|
| UBS Group | 988.00 | $18k | 100% | Mar 2024 |
|
| City Holding | 400.00 | $7.4k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 392.00 | $7.3k | 100% | Mar 2024 |
|
| Bank Of Montreal | 300.00 | $5.7k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 160.00 | $2.9k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 25.00 | $0 | 100% | Mar 2024 |
|